Global healthcare spending trends and government regulatory policies on drug pricing, impacting revenue and profitability for pharmaceutical companies like Roche.

Advances in medical research and development, including competition in therapeutic areas such as oncology and neuroscience, which can influence Roche's market share and future product pipeline.

Demographic shifts, particularly an aging global population, increasing the prevalence of age-related diseases and demand for diagnostic tools and pharmaceutical treatments.